2 results
Not approvedWill not start
The objective is to investigate the accuracy, feasibility and safety of FFR in patients presenting with STEMI and MVD.
Approved WMOWill not start
Pertuzumab is an investigational agent being studied for the treatment of HER2-positive gastric cancer. This study intends to provide a dose of pertuzumab to find an acceptable minimum pertuzumabconcentratie pertuzumab effective when administered in…